Lee KW, Zang DY, Kim HD, Kim JW, et al. Correction: Multicenter phase Ib/II study of second-line durvalumab and tremelimumab in combination with paclitaxel in patients with biomarker-selected metastatic gastric cancer. Br J Cancer 2025 Nov 11. doi: 10.1038/s41416-025-03267.
PMID: 41219392